West Hartford, CT, United States of America

Hoon Kim

This inventor holds 1 USPTO granted patent. Top assignee: Henry Ford Health System. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hoon Kim. Retrieved from https://idiyas.com/inventor/hoon-kim-85fbcvvl

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Hoon Kim: Innovator in Targeted Cancer Treatment

Introduction

Hoon Kim is an accomplished inventor based in West Hartford, CT (US). He has made significant contributions to the field of oncology through his innovative research and development efforts. His work focuses on targeted therapies for cancer treatment, particularly glioblastoma.

Latest Patents

Hoon Kim holds a patent for a groundbreaking method titled "A Method of Targeting Patient-Specific Oncogenes in Extrachromosomal DNA to Treat Glioblastoma." This patent represents a significant advancement in personalized medicine, aiming to improve treatment outcomes for patients suffering from this aggressive form of brain cancer. He has 1 patent to his name.

Career Highlights

Hoon Kim is affiliated with the Henry Ford Health System, where he continues to push the boundaries of cancer research. His work is characterized by a commitment to developing innovative solutions that address the complexities of cancer treatment.

Collaborations

Throughout his career, Hoon has collaborated with notable colleagues, including Roel Verhaak and Ana Decarvalho. These partnerships have fostered a collaborative environment that enhances the potential for groundbreaking discoveries in cancer treatment.

Conclusion

Hoon Kim's contributions to the field of oncology through his innovative patent and collaborative efforts highlight his dedication to improving cancer treatment. His work exemplifies the impact of targeted therapies in the fight against glioblastoma.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…